Vital Highlights 2014-2021

SARRP ( SMALL ANIMAL RADIATION RESEARCH PLATFORM )

In Australia , almost 50 % of cancer patients receive radiation therapy at some time during their cancer journey . While it is painless and only takes a few minutes , there are still questions around what dose of radiation to give and for how long . The SARRP allows researchers to study the effect of radiation on tumours , and healthy cells and tissues , in order to develop new treatment combinations for cancer patients . For example , the addition of radiosensitiser and radioprotective agents , as well as novel chemotherapeutic and immunotherapeutic drugs . Our multi - disciplinary team and patient - centric focus ensures that there is bi - lateral communication of highly clinically relevant questions and findings between the laboratory and clinic . The SAARP is the only image guided small animal radiation research platform ( Xstrahl SARRP ) in Australia . In combination with the expertise of the Flagship 1 team in inflammation research and pre - clinical cancer modelling , this facility has led to many multi - institutional and inter - disciplinary collaborations . As a result , a new infrastructure pipeline for advancing cancer therapeutics ( PACT ) was established with funding from Sydney Vital and the Mark Hughes Foundation . The pipeline is available to researchers across the state to assist in pre - clinical assessment of novel therapies .

Learn more about SARRP here .

P A G E 4 9

Made with FlippingBook - professional solution for displaying marketing and sales documents online